LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible

Rybelsus (semaglutide) is the only oral GLP-1 receptor agonist licensed in the UK for type 2 diabetes, but it must never be broken, split, crushed, or chewed. The tablets contain a sophisticated formulation with an absorption enhancer that allows the peptide medication to survive stomach acid and enter the bloodstream. Altering the tablet in any way destroys this delivery system, significantly reducing effectiveness and potentially compromising blood glucose control. If you have concerns about swallowing Rybelsus or your prescribed dose, speak with your GP or diabetes specialist nurse rather than modifying the tablet yourself.
Quick Answer: Rybelsus tablets must never be broken, split, crushed, or chewed, as doing so destroys the specialised formulation required for oral absorption and significantly reduces medication effectiveness.
No, you should never break, split, crush, or chew Rybelsus tablets. Rybelsus (semaglutide) is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes mellitus. It is currently the only oral formulation of a glucagon-like peptide-1 (GLP-1) receptor agonist approved for use in the UK. The tablets are specifically designed to be swallowed whole, and altering them in any way can significantly reduce their effectiveness.
According to the UK Summary of Product Characteristics (SmPC), Rybelsus tablets must not be split, crushed, or chewed. This is not simply a recommendation but a critical requirement for the medication to work as intended. Breaking the tablet compromises its unique formulation, which has been engineered to overcome the challenges of delivering a peptide medication orally.
If you are finding it difficult to swallow Rybelsus tablets, or if you have concerns about the tablet size or your prescribed dose, it is essential to speak with your GP or diabetes specialist nurse rather than attempting to modify the tablet yourself. There may be alternative treatment options available, or your healthcare team can provide advice on swallowing techniques. Never adjust your medication without professional guidance, as doing so may result in inadequate blood sugar control and potentially serious health consequences.

Rybelsus contains a sophisticated pharmaceutical formulation that enables semaglutide—a large peptide molecule—to be absorbed through the stomach lining. Under normal circumstances, peptide medications like semaglutide would be broken down by stomach acid and digestive enzymes before they could enter the bloodstream, which is why most GLP-1 receptor agonists (such as Ozempic or Trulicity) must be given by injection.
The key to Rybelsus's oral delivery is a special absorption enhancer called sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). According to the European Medicines Agency's assessment report, this compound works by increasing the local pH in the stomach and enhancing the transcellular absorption of semaglutide, allowing it to pass into the bloodstream before degradation. The tablet is designed to release SNAC and semaglutide in a specific manner to facilitate absorption.
When you break, crush, or chew a Rybelsus tablet, you disrupt this carefully designed delivery system. The absorption enhancer and active ingredient may not function as intended, potentially reducing the amount of semaglutide that reaches your bloodstream. Clinical studies that established Rybelsus's efficacy and safety were conducted using whole tablets, and there is no evidence to support the effectiveness of modified tablets.
The specific formulation of Rybelsus is essential to its function, which is why the manufacturer and regulatory authorities emphasise that tablets must be swallowed whole.
If you accidentally or intentionally break, split, or crush a Rybelsus tablet before taking it, the medication is unlikely to work effectively. The disruption to the tablet's formulation means that less semaglutide may be absorbed into your bloodstream, potentially resulting in inadequate blood glucose control. This could lead to persistently elevated blood sugar levels, increasing your risk of both short-term symptoms and long-term diabetes complications.
In the short term, reduced medication effectiveness may cause:
Hyperglycaemia symptoms including increased thirst, frequent urination, fatigue, and blurred vision
Loss of the appetite-suppressing effects that some patients experience
Fluctuating blood glucose readings that make diabetes management more difficult
The safety and efficacy of taking split or crushed Rybelsus tablets have not been established. If you have accidentally damaged a tablet, do not attempt to take the pieces. Instead, treat it as a missed dose, discard the damaged tablet safely (return it to your pharmacy if possible) and take your next scheduled dose as normal. Do not take an extra tablet to compensate, as this could lead to overdose.
If you have been regularly breaking your Rybelsus tablets, contact your GP or diabetes care team promptly. They will need to review your recent blood glucose control and may recommend additional monitoring. Your HbA1c levels may have risen during this period, requiring adjustment to your diabetes management plan.
Important safety note: Seek urgent medical help if you experience severe, persistent abdominal pain (which could indicate pancreatitis), persistent vomiting leading to dehydration, or sudden vision changes while taking Rybelsus. Report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
To achieve optimal therapeutic benefit from Rybelsus, it is essential to follow the specific administration instructions precisely. Rybelsus must be taken on an empty stomach, first thing in the morning, at least 30 minutes before eating, drinking (anything other than plain water), or taking other oral medications. This timing is crucial because food, beverages, and other medicines can significantly interfere with semaglutide absorption.
Step-by-step instructions for taking Rybelsus:
Take your tablet as soon as you wake up, before breakfast
Swallow the tablet whole with a small sip of plain water (up to 120ml)
Do not split, crush, chew, or break the tablet
Wait at least 30 minutes before eating, drinking anything other than water, or taking other medications
If you need to take other morning medications, wait the full 30 minutes after Rybelsus
Rybelsus is available in three strengths: 3mg, 7mg, and 14mg. Treatment typically begins with 3mg once daily for 30 days, which serves as an initiation dose to improve gastrointestinal tolerability. After 30 days, the dose is usually increased to 7mg once daily. If additional blood glucose control is needed after at least 30 days on 7mg, your doctor may increase the dose to 14mg once daily. Never adjust your dose without consulting your healthcare team.
If you miss a dose, skip it and take your next dose the following day at the usual time. Do not take two tablets to make up for a missed dose. If you experience persistent difficulty remembering to take Rybelsus, or if the strict timing requirements are incompatible with your lifestyle, discuss this with your GP. Alternative GLP-1 receptor agonists administered by weekly injection may be more suitable for your circumstances. Regular follow-up appointments, typically every 3–6 months, allow your healthcare team to monitor your HbA1c, assess treatment response, and check for any adverse effects.
These administration instructions align with the UK SmPC for Rybelsus and NHS medicines information guidance.
If you accidentally break a Rybelsus tablet, do not attempt to take the pieces. Discard the damaged tablet safely (return it to your pharmacy if possible) and take your next scheduled dose as normal the following day. Do not take an extra tablet to compensate.
Rybelsus contains a special absorption enhancer (SNAC) that protects semaglutide from stomach acid and enables absorption through the stomach lining. Crushing the tablet destroys this delivery system, preventing the medication from working effectively.
If you have difficulty swallowing Rybelsus tablets, speak with your GP or diabetes specialist nurse. Alternative GLP-1 receptor agonists administered by weekly injection (such as Ozempic or Trulicity) may be more suitable for your circumstances.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.